Bromelain exerts anti-inflammatory effects in an ovalbumin-induced murine model of allergic airway disease

Bromelain attenuated development of AAD while altering CD4+ to CD8+ T lymphocyte populations. The reduction in AAD outcomes suggests that bromelain may have similar effects in the treatment of human asthma and hypersensitivity disorders.